Results 91 to 100 of about 1,675 (195)

Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment

Haematologica, 2002
BACKGROUND AND OBJECTIVES: Clinical and pathologic variability of post-transplant lymphoproliferative disorders (PTLDs), their aggressive behavior and the recognized therapy-related toxicity make management of patients with these disorders difficult ...
G Muti, S Cantoni, P Oreste, C Klersy, G Gini, V Rossi, G D'Avanzo, P Comoli, F Baldanti, M Montillo, A Nosari, E Morra, Cooperative Study Group on PTLDs   +12 more
doaj  

Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders an immunohistochemical and molecular study of 52 cases

, 2009
sosttransplant lymphoproliferative disorders (PTLDs), a heterogeneous group of monoclonal or polyclonal lesions, occur in immunosuppressedpatients after solid organ or bone marrow transplantation.
Chen, Wei, Weiss, Lawrence M., Rowsell, Edward H., Cao, Jeffrey D., Huang, Qin, Wang, Jun, Zuppan, Craig W.   +6 more
core   +1 more source

Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome

International Medical Case Reports Journal, 2017
Ashraf F Hanna, Bishoy Abraham, Andrew Hanna, Adam J Smith Department of Pain Management, Florida Spine Institute, Clearwater, FL, USA Abstract: Post-treatment Lyme disease syndrome (PTLDS) is a pain disorder for which there remains no ...
Hanna AF, Abraham B, Hanna A, Smith AJ
doaj  

Improving biomarkers of inflammation including phosphorylated tau in a patient with chronic Lyme disease/post-treatment Lyme disease syndrome using dapsone combination therapy: A case study and literature review

Journal of Alzheimer's Disease Reports
Background Borrelia burgdorferi , the agent of Lyme disease, has been found to co-localize in Alzheimer's disease autopsy brain tissues with biofilm, amyloid, and phosphorylated tau.
Richard Horowitz
doaj   +1 more source

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

, 2019
We studied the expression of programed death 1 (PD-1) receptor and its ligands (PD-L1/-L2) by immunohistochemistry and its association with clinicopathological features in 81 posttransplant lymphoproliferative disorders (PTLDs) following solid organ ...
Enblad, Gunilla, Molin, Daniel, Molin, Daniel,, Sundström, Christer, Backlin, Carin,, Kinch, Amelie, Kinch, Amelie,, Enblad, Gunilla,, Baecklund, Eva, Backlin, Carin, Sundström, Christer,, Baecklund, Eva,   +11 more
core   +1 more source

Preventing PTLD? [PDF]

American Journal of Transplantation, 2018
openaire   +1 more source

Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review

Microorganisms
Three patients with relapsing and remitting borreliosis, babesiosis, and bartonellosis, despite extended anti-infective therapy, were prescribed double-dose dapsone combination therapy (DDDCT) for 8 weeks, followed by one or several two-week courses of ...
Richard I. Horowitz, John Fallon, Phyllis R. Freeman   +2 more
doaj   +1 more source

Rituximab for PTLD of the CNS: Is It a ‘No-Brainer’? [PDF]

Oncology Research and Treatment, 2008
Ran Reshef, Donald E. Tsai
openaire   +1 more source

DP010 | POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: MULTICENTER OBSERVATIONAL RETROSPECTIVE COHORT STUDY OF THE ITALIAN LYMPHOMA FOUNDATION

Haematologica
Background and Aims. Post-transplant lymphoproliferative disorders (PTLDs) are rare complications occurring either after solid organ (SOT) or hematopoietic stem cell (HSCT) transplantation, with an overall incidence of about 1% at 10 years.
C. Consoli, P. Minga, P.L. Zinzani, A. Ferreri, F.G. Rossi, A. Castellino, M. Spina, R. Bruna, L. Petrucci, L. Arcaini, A.M. Barbui, B. Botto, E. Cencini, S. Hohaus, D. Marino, J. Olivieri, B. Puccini, A. Re, O. Annibali, M. Riva, A. Tafuri, S.V. Usai, A. Evangelista, B. Bruno, F. Cavallo   +24 more
doaj  

The conflict on posttreatment Lyme disease syndrome: a clinical mini review

, 2016
Is Borrelia burgdorferi responsible for the persistence of symptoms after the standard successful course of antibiotics in Lyme disease patients? This highly controversial issue, concerning the underlying mechanism of posttreatment Lyme disease syndrome (
Bogdos, Manos, Giannopoulos, Sotirios, Kosmidou, Maria   +2 more
core